Showing results (21-30 of 137) with videos related to
Sort By:
Pageof 14
Biomedical Physics & Engineering Express|May 28, 2026
Bioglass and zinc incorporated PCL based composite as biodegradable implants for bone fixationTapas Das, Srija Panda, Rajib Dey, et al.Molecular Imaging and Biology|July 20, 2014
Radiosynthesis and bioevaluation of [68Ga]-labeled 5,10,15,20-tetra(4-methylpyridyl)-porphyrin for possible application as a PET radiotracer for tumor imagingMohini Bhadwal, Tapas Das, Haladhar Dev Sarma, et al.Cancer Biotherapy & Radiopharmaceuticals|December 15, 2021
Estimation of Absorbed Doses of Indigenously Produced "Direct-route" Lutetium-177-[177Lu]Lu-DOTA-TATE PRRT in Normal Organs and Tumor Lesions in Patients of Metastatic Neuroendocrine Tumors: Comparison with No-Carrier-Added [177Lu]Lu-DOTA-TATE and the Trend with Multiple CyclesKamaldeep, Sarvesh Loharkar, Tapas Das, et al.Chemical Communications (Cambridge, England)|August 26, 2016
Highly fluorescent 1,2-dihydropyrimido[1,6-α]indole: an efficient metal free synthesis and photophysical studyTapas Das, Anirban Kayet, Ruchika Mishra, et al.Current Radiopharmaceuticals|September 1, 2012
109Pd labeled 5,10,15,20-tetrakis[4-carboxymethyleneoxyphenyl]porphyrin: a potential agent for targeted tumor therapyTapas Das, Sudipta Chakraborty, H D Sarma, et al.Clinical Nuclear Medicine|November 8, 2016
Theranostic Treatment of Metastatic Bone Pain With 177Lu-DOTMPTapas Das, Ajit Shinto, Koramadai Karuppuswamy Kamaleshwaran, et al.Cancer Biotherapy & Radiopharmaceuticals|September 7, 2017
Preparation and Evaluation of 177Lu-Labeled Gemcitabine: An Effort Toward Developing Radiolabeled Chemotherapeutics for Targeted Therapy ApplicationsSubhajit Ghosh, Tapas Das, Haladhar D Sarma, et al.Drug Development Research|January 31, 2018
The potential of radiolabeled chemotherapeutics in tumor diagnosis: Preliminary investigations with 68 Ga-gemcitabineSubhajit Ghosh, Tapas Das, Haladhar D Sarma, et al.Indian Journal of Pharmacology|March 22, 2016
Pill burden does not influence compliance with oral medication in recipients of renal transplantUma Rani Adhikari, Abhijit Taraphder, Avijit Hazra, et al.Clinical Nuclear Medicine|January 11, 2017
170Tm-EDTMP: A Prospective Alternative of 89SrCl2 for Theranostic Treatment of Metastatic Bone PainTapas Das, Ajit Shinto, Koramadai Karuppuswamy Kamaleshwaran, et al.Pageof 14